Litcius/Paper detail

Is the new angel better than the old devil? Challenges and opportunities in CD47- SIRPα-based cancer therapy

Olamide Tosin Olaoba, Kehinde Sulaimon Ayinde, Olubodun Michael Lateef, Michael Olawale Akintubosun, Khadijat Ayodeji Lawal, Temitope Isaac Adelusi

2023Critical Reviews in Oncology/Hematology13 citationsDOI

Topics & Concepts

CD47ImmunosurveillanceTumor microenvironmentImmune systemMyeloid cellsImmunotherapyCancerCancer therapyBiologyImmunologyCancer researchGeneticsPhagocytosis and Immune RegulationImmune cells in cancerImmunotherapy and Immune Responses
Is the new angel better than the old devil? Challenges and opportunities in CD47- SIRPα-based cancer therapy | Litcius